(Stroke. 1996;27:317-323.)
© 1996 American Heart Association, Inc.
Articles |
Aminoguanidine Ameliorates and L-Arginine Worsens Brain Damage From Intraluminal Middle Cerebral Artery Occlusion
From the Laboratories of Cerebrovascular Biology and Stroke (F.Z., C.I., R.M.C.) and Molecular Neurobiology and Development (R.M.C., M.E.R.), Department of Neurology, University of Minnesota Medical School, Minneapolis.
Correspondence to C. Iadecola, MD, Department of Neurology, University of Minnesota Medical School, Box 295 UMHC, 420 Delaware St SE, Minneapolis, MN 55455.
Background and Purpose We studied whether the inducible nitric oxide synthase (iNOS) inhibitor aminoguanidine reduces focal cerebral ischemic damage in a relatively noninvasive stroke model in which the rat middle cerebral artery (MCA) is occluded using an intravascular filament.
Methods In rats anesthetized with halothane, a nylon filament was advanced into the internal carotid artery until its tip occluded the origin of the MCA. The filament was left in place for 2 hours and then withdrawn. Twenty-four hours later, rats received intraperitoneal injections of aminoguanidine (100 mg/kg BID; n=7), aminoguanidine+L-arginine (300 mg/kg QID; n=7), L-arginine alone (n=6), D-arginine alone (n=6), or vehicle (n=10). Drugs were administered for 3 consecutive days. Infarct volume was determined by image analysis in thionin-stained brain sections 4 days after ischemia. iNOS mRNA was detected with the use of reverse transcription polymerase chain reaction.
Results Cerebral ischemia led to iNOS mRNA expression in the affected brain 48 hours after induction of ischemia. Administration of aminoguanidine reduced neocortical infarct volume by 26% (P<.05 versus vehicle, ANOVA and Tukey's test), a reduction that was antagonized by coadministration of L-arginine (P>.05 versus vehicle). Administration of L-arginine alone, but not D-arginine, enlarged the infarct by 29% (P<.05). Aminoguanidine or L-arginine did not influence the increase in water content in the postischemic brain, indicating that the effect on infarct volume is not related to modulation of ischemic edema.
Conclusions These results demonstrate that cerebral ischemia is also associated with iNOS expression in a minimally invasive model of transient MCA occlusion and that iNOS inhibition reduces focal ischemic damage. The findings support the hypothesis that nitric oxide produced by iNOS contributes to ischemic brain damage and that inhibition of iNOS may be a valuable tool in the management of cerebral ischemia.
Key Words: middle cerebral artery occlusion • nitric oxide • stroke, experimental • rats
This article has been cited by other articles:
 |
|
 |
|
  A. Kunz, T. Abe, K. Hochrainer, M. Shimamura, J. Anrather, G. Racchumi, P. Zhou, and C. Iadecola Nuclear Factor-{kappa}B Activation and Postischemic Inflammation Are Suppressed in CD36-Null Mice after Middle Cerebral Artery Occlusion J. Neurosci., February 13, 2008; 28(7): 1649 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. W.T. Liu and P. L. Huang Cardiovascular roles of nitric oxide: A review of insights from nitric oxide synthase gene disrupted mice Cardiovasc Res, January 1, 2008; 77(1): 19 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kazachkov, K. Chen, S. Babiy, and P. H. Yu Evidence for in Vivo Scavenging by Aminoguanidine of Formaldehyde Produced via Semicarbazide-Sensitive Amine Oxidase-Mediated Deamination J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1201 - 1207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Vagnerova, P. D. Hurn, A. Bhardwaj, and J. R. Kirsch Sigma 1 receptor agonists act as neuroprotective drugs through inhibition of inducible nitric oxide synthase. Anesth. Analg., August 1, 2006; 103(2): 430 - 4, table of contents. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Culmsee, N. Gerling, S. Landshamer, B. Rickerts, H.-J. Duchstein, K. Umezawa, S. Klumpp, and J. Krieglstein Nitric Oxide Donors Induce Neurotrophin-Like Survival Signaling and Protect Neurons against Apoptosis Mol. Pharmacol., October 1, 2005; 68(4): 1006 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Heneka, M. Sastre, L. Dumitrescu-Ozimek, A. Hanke, I. Dewachter, C. Kuiperi, K. O'Banion, T. Klockgether, F. Van Leuven, and G. E. Landreth Acute treatment with the PPAR{gamma} agonist pioglitazone and ibuprofen reduces glial inflammation and A{beta}1-42 levels in APPV717I transgenic mice Brain, June 1, 2005; 128(6): 1442 - 1453. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. FENG and M. H. LeBLANC Effect of Agmatine on the Time Course of Brain Inflammatory Cytokines After Injury in Rat Pups Ann. N.Y. Acad. Sci., December 1, 2003; 1009(1): 152 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cherian, G. Chacko, C. Goodman, and C. S. Robertson Neuroprotective Effects of L-Arginine Administration after Cortical Impact Injury in Rats: Dose Response and Time Window J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 617 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. K. Boje, D. Jaworowicz Jr., and J. J. Raybon Neuroinflammatory Role of Prostaglandins during Experimental Meningitis: Evidence Suggestive of an in Vivo Relationship between Nitric Oxide and Prostaglandins J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 319 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Goyagi, S. Goto, A. Bhardwaj, V. L. Dawson, P. D. Hurn, and J. R. Kirsch Neuroprotective Effect of {{sigma}}1-Receptor Ligand 4-Phenyl-1-(4-Phenylbutyl) Piperidine (PPBP) Is Linked to Reduced Neuronal Nitric Oxide Production Stroke, July 1, 2001; 32(7): 1613 - 1620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Fassbender, M. Fatar, A. Ragoschke, M. Picard, T. Bertsch, S. Kuehl, and M. Hennerici Subacute But Not Acute Generation of Nitric Oxide in Focal Cerebral Ischemia Stroke, September 1, 2000; 31(9): 2208 - 2211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Reglodi, A. Somogyvari-Vigh, S. Vigh, T. Kozicz, A. Arimura, and S. P. Finklestein Delayed Systemic Administration of PACAP38 Is Neuroprotective in Transient Middle Cerebral Artery Occlusion in the Rat Editorial Comment Stroke, June 1, 2000; 31(6): 1411 - 1417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. K. Boje and S. S. Lakhman Nitric Oxide Redox Species Exert Differential Permeability Effects on the Blood-Brain Barrier J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 545 - 550. [Abstract] [Full Text]
|
|
|
|
|
|
J. Castillo, R. Rama, and A. Davalos Nitric Oxide-Related Brain Damage in Acute Ischemic Stroke Stroke, April 1, 2000; 31(4): 852 - 857. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Davis and D. Barer Neuroprotection in acute ischaemic stroke. II: Clinical potential Vascular Medicine, August 1, 1999; 4(3): 149 - 163. [Abstract] [PDF]
|
|
|
|
 |
|
 D. O'MAHONY and M. J KENDALL Nitric oxide in acute ischaemic stroke: a target for neuroprotection J. Neurol. Neurosurg. Psychiatry, July 1, 1999; 67(1): 1 - 3. [Full Text]
|
|
|
|
 |
|
 H.-C. Lin, F.-J. Wan, B.-H. Kang, C.-C. Wu, and C.-J. Tseng Systemic Administration of Lipopolysaccharide Induces Release of Nitric Oxide and Glutamate and c-fos Expression in the Nucleus Tractus Solitarii of Rats Hypertension, May 1, 1999; 33(5): 1218 - 1224. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ivanova, G. I. Botchkina, Y. Al-Abed, M. Meistrell III, F. Batliwalla, J. M. Dubinsky, C. Iadecola, H. Wang, P. K. Gregersen, J. W. Eaton, et al. Cerebral Ischemia Enhances Polyamine Oxidation: Identification of Enzymatically Formed 3-Aminopropanal as an Endogenous Mediator of Neuronal and Glial Cell Death J. Exp. Med., July 20, 1998; 188(2): 327 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. FARACI and D. D. HEISTAD Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels Physiol Rev, January 1, 1998; 78(1): 53 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Samdani, T. M. Dawson, and V. L. Dawson Nitric Oxide Synthase in Models of Focal Ischemia Stroke, June 1, 1997; 28(6): 1283 - 1288. [Abstract] [Full Text]
|
|
|
|
|
|
S. Nogawa, F. Zhang, M. E. Ross, and C. Iadecola Cyclo-Oxygenase-2 Gene Expression in Neurons Contributes to Ischemic Brain Damage J. Neurosci., April 15, 1997; 17(8): 2746 - 2755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Iadecola, F. Zhang, R. Casey, H. B. Clark, M. E. Ross, and R. C Kukreja Inducible Nitric Oxide Synthase Gene Expression in Vascular Cells After Transient Focal Cerebral Ischemia Stroke, August 1, 1996; 27(8): 1373 - 1380. [Abstract] [Full Text]
|
|